Key Events This Week
10 Aug: MarketsMOJO upgrades GKB Ophthalmics to Hold on improving technicals and financials
13 Aug: Company reports mixed quarterly results with declining sales but improved profitability
14 Aug: Stock closes at ₹65.00, marking an 11.32% weekly gain

GKB Ophthalmics Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends
2026-08-13 12:00:13GKB Ophthalmics Ltd has demonstrated a cautiously optimistic financial performance in the quarter ended June 2026, with key profitability metrics improving despite a contraction in quarterly net sales. The company’s recent upgrade to a 'Hold' rating reflects a shift from previous concerns, underpinned by stronger returns on capital and higher profit after tax over the last six months.
Read full news article
GKB Ophthalmics Ltd Upgraded to Hold as Technicals and Financials Show Improvement
2026-08-11 08:31:09GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial results. The upgrade, effective from 10 August 2026, is driven by a combination of enhanced technical trends, robust quarterly earnings, attractive valuation metrics, and a cautiously optimistic financial trajectory despite some lingering fundamental weaknesses.
Read full news article
GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Technical Weakness
2026-07-07 08:34:40GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 July 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive quarterly results, the company’s long-term fundamentals and technical trends have deteriorated, prompting a reassessment of its outlook within the healthcare services sector.
Read full news article
GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance
2026-07-01 08:12:36GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, valuation metrics, and evolving market trends have collectively influenced this reassessment, signalling cautious optimism among investors despite lingering long-term challenges.
Read full news article







